Introduction
============

RNA interference (RNAi) mediates plant defense against virus infections ([@B8]; [@B15]; [@B24]). DICER-LIKE ribonucleases (DCLs), such as DCL4, generate viral short interferencing RNAs (siRNAs) ([@B3]; [@B28]), which direct the loading of viral RNAs into ARGONAUTE (AGO) proteins (e.g., AGO1) of the RNA-induced silencing complex (RISC) for the cleavage of viral RNAs ([@B27]; [@B1]; [@B2]), resulting in RNAi-mediated antiviral immunity. RNA-dependent RNA polymerases (RDRs) ([@B38]; [@B35]; [@B6]), including RDR1 and RDR6, promote synthesis of siRNAs by synthesizing long double-strand RNAs (dsRNAs), contributing to the antiviral immunity ([@B30]; [@B13]).

Viruses in turn evolve viral suppressor of RNAi (VSR) to suppress host antiviral immunity. For example, Cucumber Mosaic Virus (CMV) utilizes the VSR protein 2b ([@B40]; [@B7]) to suppress host RNAi-based antiviral immunity and causes severe pathogenic responses in wild-type *Arabidopsis*, while CMV2aTΔ2b, a CMV mutant without expression of 2b protein, is unable to cause any obvious viral symptoms in wild-type and the single mutants of *RDR1* or *RDR6*, but is able to cause severe pathogenic responses in the RNAi-deficient double mutant *rdr1 rdr6* ([@B37]).

Aminophospholipid transporting ATPases (ALAs) are membrane-localized flippases that are responsible for transporting different lipids, which is essential for asymmetry of membrane lipid bilayers ([@B19], [@B20]; [@B4]). There are 12 *Arabidopsis thaliana* ALAs in the IV subfamily of ATPases that control plant development or tolerance to temperature stresses ([@B21]). ALA1 is required for plant tolerance to chilling ([@B14]). ALA3 regulates pollen germination and pollen tube growth, and adaptability to chilling ([@B29]; [@B26]). ALA6 and ALA7 control temperate-regulated pollen tube elongation ([@B25]). ALA10 affects lipid uptake to regulate root growth and stomatal control ([@B4]).

In this study, we performed a forward genetic screening for enhancers of *rdr6* with CMV2aTΔ2b infection on M2 population of ethyl methanesulfonate (EMS)-mutagenized *rdr6*. We show that ALA1 and ALA2 act additively with RDR1 and RDR6 to mediate RNAi-mediated antiviral immunity and development. Our findings discover novel roles of ALA1 and ALA2.

Materials and Methods {#s1}
=====================

Materials and Growth Conditions
-------------------------------

The *Arabidopsis thaliana* mutants *ala1-2* (Salk_056947), *ala3* (GK-317H04), *ala7* (Salk_125598) and *ala10* (Salk_024877) were obtained from Arabidopsis Biological Resource Center. The *Arabidopsis* mutants *rdr1-1* (SAIL_672_F11), *rdr6-15* (SAIL_617H07), *rdr1 rdr6*, the L1 line transgenic for GUS, and the 2b-deficient CMV mutant CMV2aTΔ2b were described as previously ([@B5]; [@B37]). The *ala1-2 rdr1, ala1-2 rdr6* and *ala1-2 rdr1 rdr6* were generated via genetic crossing. *Nicotiana benthamiana* was grown under a 16-h (28°C)/8-h (22°C) light/dark condition.

For observation of growth defects in **Figure [5C](#F5){ref-type="fig"}** and fertility and siliques development in **Figure [3](#F3){ref-type="fig"}**, *Arabidopsis* seeds were sterilized with 20% bleach, plated on Murashige and Skoog (MS) medium, chilled at 4°C for 3 days, and transferred to a growth room under a 16-h (23--25°C)/8-h (18--20°C) light/dark photoperiod for 9 days. The 9-day-old seedlings were transplanted into soil and grew in the same growth room for another ∼3 or ∼6 weeks.

Viral Infection
---------------

For viral infection assays, *Arabidopsis* seedlings were sterilized, plated on MS medium, chilled at 4°C for 3 days, and transferred to a growth room under a 16-h (23--25°C)/8-h (18--20°C) light/dark photoperiod for 9 days. The 9-day-old seedlings were transplanted into soil for growth of another 14 days in a growth room under an 8-h (22--24°C)/16-h (16--19°C) light/dark photoperiod. The 23-day-old plants were inoculated with CMV2aTΔ2b as described previously ([@B37]), and the disease symptoms were recorded at 21 or 45 days after infection.

EMS Mutagenesis
---------------

About 20,000 seeds (M1) of the *Arabidopsis* mutant *rdr6-15* (SAIL_617H07) were soaked with 100 mM phosphate buffer (pH 7.5) overnight at 4°C, washed with sterilized water for five times, and mutagenized with 0.6% ethyl methanesulfonate (EMS) dissolved in phosphate buffer for 8 h at room temperature. The mutagenized seeds were washed with sterilized water for 20 times, and were grown in soil for collection of M2 seeds.

Generation of Mutants and Transgenic Plants
-------------------------------------------

Mutations at 698th (-), 1120th (+) and 2216th (+) bp of coding sequence (CDS) of *ALA1* (Supplementary Figure [1B](#SM1){ref-type="supplementary-material"}), and at the 951th (+) bp of CDS of *ALA2* (Supplementary Figure [5B](#SM1){ref-type="supplementary-material"}) were introduced into the *rdr6* mutant through CRISPR/Cas9 method ([@B23]). The guide RNA of the CRISPR target was driven by U6 promoter, and Cas9 was under control of a CaMV35S promoter in a modified pCAMBIA1300 vector ([@B23]). Primers used for construction of vectors are listed in Supplementary Table [1](#SM1){ref-type="supplementary-material"}. The constructs were introduced into *rdr6* mutants through agrobacterium-mediated flower dip method. The transgenic seeds were selected on MS containing 20 mg/L hygromycin, T2 plants were inoculated with CMV2aTΔ2b. Mutations of *ALA1* or *ALA2* were confirmed by sequencing.

The CDS of *ALA1* was cloned into the pCAMBIA1300 vector through SmaI and XbaI sites for fusion with three FLAG tags under the control of CaMV35S promoter, and introduced into the *ala1-2* using agrobacterium-mediated flower dip method.

Whole-Genome Sequencing and Gene Cloning of *ENOR* Loci
-------------------------------------------------------

The F2 population generated by crossing *enor1 rdr6* or *enor2 rdr6* with *rdr6* were inoculated with CMV2aTΔ2b. One hundred susceptible plants from F2 population were harvested at 21 days after inoculation to generate a bulked pool for DNA extraction with DNeasy Plant Maxi Kit (QIAGEN, Cat. 68163) and construction of DNA library. Whole genome sequencing was performed with the illumina HiSeq2000 platform. The softwares Skewer, Bowtie2 and SHOREmap were used to analyze the data and isolate mutations ([@B32]; [@B34]). The SNP-based Cleaved Amplified Polymorphic Sequences (CAPSs) markers generated from comparison of genome sequences of *enor1 rdr6* or *enor2 rdr6* with *rdr6* were used to assist mapping and cloning of *ENOR1* and *ENOR2*.

Immunoblotting Analysis
-----------------------

The total proteins were extracted from plants at 21 days after inoculation with mock or CMV2aTΔ2b. Fifty microgram of total protein for each sample was quantified and loaded for detection of coat protein (CP) of CMV2aTΔ2b. The antibody against coat protein (anti-CP) of CMV2aTΔ2b was produced by Abmart company (Abmart^[1](#fn01){ref-type="fn"}^) with the recombinant protein of the 1st to 154th AA of CP. The anti-CP was used as first antibody (1:6000), and anti-rabbit immunoglobulin antibody was used as the secondary antibody respectively (1:3000). All of the experiments were repeated at least three biological times.

GUS Staining
------------

The L1 line transgenic for the β-glucuronidase (*GUS*) gene driven by 35S promoter (*35S::GUS*), in which the *GUS* activity is very low in all the expanded rosette leaves due to the post transcriptional gene silencing ([@B5]), was crossed with *ala1-2* to generate *ala1-2* with L1 transgene (*35S::GUS*), named *ala1-2 35S::GUS*. Eighteen *ala1-2 35S::GUS* plants were used for histochemical staining of GUS using the method described previously ([@B33]).

Quantitative Real-Time PCR Analysis
-----------------------------------

For **Figure [6A](#F6){ref-type="fig"}**, the expression of *ALA* family members was analyzed in Col-0 and *ala1-2* at 21 days after inoculation with mock or CMV2aTΔ2b. For Supplementary Figure [4](#SM1){ref-type="supplementary-material"}, the accumulation of genomic RNA of CMV2aTΔ2b was analyzed in Col-0 and *ala1-2* at 21 days after CMV2aTΔ2b inoculation. The primers used for RNA detection of CMV2aTΔ2b were designed based on the conserved sequences from genomic RNA1 to RNA3 in the 3 prime end. The materials were harvested for RNA extraction using trizol (TRANSGENE, Cat.ET101-01), and reverse transcription was performed according to the kit (TRANSGENE, Cat. AT311-03). Quantitative real-time PCR was performed with EvaGreen 2^∗^qPCR MasterMix-Low ROX reagents (ABM, Cat. Mastermix-LR) using the ABI7500 real-time PCR system. *ACTIN8* was used as the internal control. All of the experiments were repeated at least three biological times. Primers used for quantitative real-time PCR analysis are listed in Supplementary Table [1](#SM1){ref-type="supplementary-material"}.

Phylogenetic Analysis
---------------------

For the phylogenetic analysis shown in Supplementary Figure [6](#SM1){ref-type="supplementary-material"}, the evolutionary history was inferred using the Neighbor-Joining method ([@B31]). The optimal tree with the sum of branch length (4.45679805) is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) are shown next to the branches ([@B10]). The evolutionary distances were computed using the Poisson correction method ([@B41]) and are in the units of the number of amino acid substitutions per site. The analysis involved all 12 amino acid sequences of ALA family. All positions containing gaps and missing data were eliminated. There were a total of 794 positions in the final dataset. Evolutionary analyses were conducted in MEGA6 ([@B36]). The transcripts, including ALA1 (AT5G04930.1), ALA2 (AT5G44240.1), ALA3 (AT1G59820.1), ALA4 (AT1G17500.1), ALA5 (AT1G72700.1), ALA6 (AT1G54280.1), ALA7 (AT3G13900.1), ALA8 (AT3G27870.1), ALA9 (AT1G68710.1), ALA10 (AT3G25610.1), ALA11 (AT1G13210.1), and ALA12 (AT1G26130.2), were used for phylogenetic analysis.

Subcellular Localization
------------------------

Coding sequence of *ALA1* was cloned into the pJG054 vector for fusion with YFP under control of CaMV35S promoter (*YFP-ALA1*). The agrobacterium containing *YFP-ALA1* or the mCherry-ER-marker were resuspended in the infiltration buffer (10 mM MgCl~2~, 10 mM MES, 0.2 mM acetosyringone) for 3-5 h, and co-infiltrated into leaves of *N. benthamiana*. The fluorescence signals were collected with a Zeiss microscope (LSM710) at ∼50 h after co-infiltration. All of the experiments were repeated at least three biological times.

Accession Numbers
-----------------

The *Arabidopsis* Genome Initiative numbers for genes mentioned in this letter are as follows: ALA1 ([AT5G04930](AT5G04930)), ALA2 ([AT5G44240](AT5G44240)), ALA3 ([AT1G59820](AT1G59820)), ALA4 ([AT1G17500](AT1G17500)), ALA5 ([AT1G72700](AT1G72700)), ALA6 ([AT1G54280](AT1G54280)), ALA7 ([AT3G13900](AT3G13900)), ALA8 ([AT3G27870](AT3G27870)), ALA9 ([AT1G68710](AT1G68710)), ALA10 ([AT3G25610](AT3G25610)), ALA11 ([AT1G13210](AT1G13210)), ALA12 ([AT1G26130](AT1G26130)), RDR1 ([AT1G14790](AT1G14790)), RDR6 ([AT3G49500](AT3G49500)), and ACTIN8 ([AT1G49240](AT1G49240)).

Results
=======

Identification and Mapping of the *enor1* Mutant
------------------------------------------------

We generated M2 population of EMS-mutagenized *rdr6*, and inoculated M2 with CMV2aTΔ2b to identify mutants that enhanced the susceptibility to CMV2aTΔ2b in *rdr6* (referred to as *enhancer of rdr6* \[*enor*\]), and utilized whole genome sequencing to assist mapping and cloning of *ENOR* loci (**Figure [1A](#F1){ref-type="fig"}**).

![***ENOR1* encodes *ALA1* and mediates antiviral immunity. (A)** Schematic diagram of screening of *enor* (enhancer *of rdr6*) mutants and mapping of *ENOR* loci. **(B)** Phenotypes of *rdr6, enor1 rdr6* and the *ala1* mutants generated by CRISPR/Cas9 in *rdr6* (*ala1-crispr1, ala1-crispr2, ala1-crispr3*) at 21 days after infection with mock or CMV2aTΔ2b. **(C)** Phenotypes of Col-0, *ala1-2* and the *ala1-2* plant transgenic for the *ALA1* gene driven by 35S promoter (*ala1-2 35S::ALA1*) at 21 days after infection with mock or CMV2aTΔ2b.](fpls-08-00422-g001){#F1}

As shown in **Figure [1B](#F1){ref-type="fig"}**, the newly identified mutant *enor1* in the *rdr6* background, named *enor1 rdr6*, exhibited severely stunted and clustered leaves after infection with CMV2aTΔ2b. One fourth of F2 population from the cross between *enor1 rdr6* and *rdr6* were susceptible to CMV2aTΔ2b, demonstrating that *enor1* is a recessive mutation. In order to map the *ENOR1* locus, we generated a bulked pool of susceptible plants from the F2 population for whole-genome sequencing, screened mutations by comparing the sequences with SHOREmap methods ([@B32]; [@B34]), and mapped the *ENOR1* locus using CAPS markers (**Figure [1A](#F1){ref-type="fig"}**). We finally found that only a C to T mutation at the 2965th bp of CDS of AT5G04930, which causes a premature stop codon and generates a HaeIII-based CAPS marker, co-segregated with *enor1* (Supplementary Figures [1A,B](#SM1){ref-type="supplementary-material"}).

*ENOR1* Corresponds to *ALA1* and Is Essential for Antiviral Immunity
---------------------------------------------------------------------

AT5G04930 encodes ALA1 ([@B21]) that co-localizes with the mCherry-ER-marker (Supplementary Figure [2](#SM1){ref-type="supplementary-material"}) ([@B20]). To further genetically verify whether AT5G04930 (*ALA1*) corresponds to *ENOR1* and mediates antiviral immunity, we generated *ala1* mutants by the CRISPR/Cas9 genome editing method ([@B11]; [@B16]) in the *rdr6* background, and examined whether these *ala1-crispr rdr6* double mutants exhibit the viral symptoms similar to that of *enor1 rdr6* when inoculated with CMV2aTΔ2b. As shown in **Figure [1B](#F1){ref-type="fig"}**, all the *ala1-crispr rdr6* double mutants were severely susceptible to CMV2aTΔ2b, demonstrating that *ALA1* corresponds to *ENOR1* and is required for antiviral immunity.

We also obtained a T-DNA insertional mutant (Salk_056947, named *ala1-2*) of *ALA1* (Supplementary Figure [1B](#SM1){ref-type="supplementary-material"}), and found that the *ala1-2* single mutant was mildly susceptible to CMV2aTΔ2b, less severe than *ala1-crispr rdr6* (**Figures [1B,C](#F1){ref-type="fig"}**), which also supports of the *ALA1* function in antiviral immunity. Moreover, we found that transgenic expression of *ALA1* under the control of CaMV 35S promoter fully restored the mutant phenotypes of *ala1-2* (**Figure [1C](#F1){ref-type="fig"}**).

*ALA1* Acts Additively With *RDR1* and *RDR6* to Regulate Antiviral Immunity
----------------------------------------------------------------------------

Further analyses of various double mutants and the triple mutant *ala1-2 rdr1 rdr6* showed that all the double mutants including *ala1-2 rdr6, ala1-2 rdr1, enor1 rdr6, ala1-crispr rdr6* and *rdr1 rdr6* exhibited similar symptoms after inoculation with CMV2aTΔ2b, which were much more severe than the single mutant *ala1-2*, while the triple mutant *ala1-2 rdr1 rdr6* showed the most severe symptoms with over-stunted newly born leaves and yellow old chlorotic leaves (**Figures [1B,C](#F1){ref-type="fig"}, [2A,B](#F2){ref-type="fig"}** and Supplementary Figure [3](#SM1){ref-type="supplementary-material"}). These results suggest that *ALA1* functions additively with *RDR1* and *RDR6* to mediate plant immunity.

![***ALA1* acts through both *RDR1*/*6*-related and -unrelated pathways to mediate antiviral immunity. (A)** Phenotypes of *rdr1 rdr6, ala1-2 rdr6, ala1-2 rdr1* and *ala1-2 rdr1 rdr6* at 21 days after infection with mock or CMV2aTΔ2b. **(B)** Phenotypes of Col-0, *rdr1 rdr6, ala1-2 rdr6* and *ala1-2 rdr1 rdr6* at 45 days after infection with mock or CMV2aTΔ2b. **(C)** Immunoblotting analysis to detect the accumulations of CMV2aTΔ2b from leaves of Col-0, *rdr6, rdr1, ala1-2, ala1-2 rdr6, ala1-2 rdr1, ala1-2 rdr1 rdr6* and *rdr1 rdr6* at 21 days after infection with mock or CMV2aTΔ2b. The coat protein (CP) of CMV2aTΔ2b was detected by anti-CP (α-CP) antibody. The large subunit of ribulose-1,5-bisphosphate was used as the loading control.](fpls-08-00422-g002){#F2}

The immunoblot analysis with antibody against the CP of CMV2aTΔ2b showed that CMV2aTΔ2b accumulated much more in *ala1-2* than in wild-type, and that the double mutants (*ala1-2 rdr6, ala1-2 rdr1* and *rdr1 rdr6*) accumulated much more CP than the corresponding single mutants (**Figure [2C](#F2){ref-type="fig"}**). These results further demonstrate that *ALA1* acts additively with *RDR1* and *RDR6* to mediate RNAi-based antiviral immunity. Interestingly, the triple mutant *ala1-2 rdr1 rdr6* showed enhanced susceptibility compared with the double mutant *rdr1 rdr6* when inoculated with CMV2aTΔ2b, however, the accumulation of CMV2aTΔ2b was indistinguishable between the triple mutant *ala1-2 rdr1 rdr6* and the double mutant *rdr1 rdr6*, implying that *ALA1* mediates plant immunity through both a *RDR1/6*-related RNAi pathway and *RDR1/6*--unrelated pathways.

Further phenotypic analysis showed that the *ala1-2 rdr1 rdr6* triple mutant also displays developmental defects, including shorter siliques and less fertile siliques (**Figures [3A](#F3){ref-type="fig"}--[C](#F3){ref-type="fig"}**). These results imply that *ALA1* may function additively with *RDR1* and *RDR6* to mediate RNAi-regulated plant development, consistent with the previous observations that RNAi, in addition to the RNAi-mediated plant immunity, also mediates plant developmental processes ([@B39]).

![***ALA1* acts additively with *RDR1* and *RDR6* to regulate plant development. (A,B)** Phenotypes **(A)** and statistical analysis of numbers of siliques with seeds **(B)** of the main inflorescences from Col-0, *rdr1 rdr6* and *ala1-2 rdr1 rdr6*. Red arrows indicate sterile siliques. Errors represent ± SE. Lowercase letters indicate significant differences by one-way ANOVA analysis with SPSS software (*P* \< 0.05). **(C)** Phenotypes of representative fertile siliques from Col-0, *rdr1 rdr6* and *ala1-2 rdr1 rdr6*. The bar represents 2 mm.](fpls-08-00422-g003){#F3}

*ALA1* Is Required for Gene Silencing
-------------------------------------

Having shown that *ALA1* acts additively with *RDR1* and *RDR6* in RNAi-based antiviral immunity and development, we further verified whether *ALA1* affects gene silencing via genetic cross of the *ala1-2* mutant with the L1, a transgenic silencing marker line where the *GUS* transgene driven by the CaMV35S promoter (*35S::GUS*) was silenced and expressed at low level ([@B5]). As shown in **Figure [4](#F4){ref-type="fig"}**, the *GUS* activity was obviously increased in *ala1-2* (named *ala1-2 35S::GUS*). These data demonstrate that mutation in *ALA1* abolished the gene silencing on the *GUS* transgene driven by the 35S promoter, suggesting that *ALA1* is indeed required for gene silencing. Consistently, our quantitative real-time PCR analysis showed that the accumulation of CMV2aTΔ2b RNA in *ala1-2* was much higher than that in Col-0, further supporting the essential roles of *ALA1* in gene silencing and antiviral defense.

![***ALA1* is involved in gene silencing.** The effect of *ala1-2* on post-transcriptional silencing of *35S::GUS* transgene of the L1 line. The *35S*::*GUS* transgene was post-transcriptionally silenced in the L1 line ([@B5]); the homozygous *ala1-2* mutation prevents silencing of the *GUS* transgene in all expanded rosette leaves of the L1 line (*ala1 35S::GUS*), which was identified from F2 population of *ala1-2* and L1.](fpls-08-00422-g004){#F4}

*ALA2* Also Participates in Antiviral Immunity
----------------------------------------------

During the screening, we isolated a second enhancer mutant *enor2 rdr6* (**Figure [5A](#F5){ref-type="fig"}**), in which CP accumulation was similar with that in *enor1 rdr6* (**Figure [5B](#F5){ref-type="fig"}**). We further found that *ENOR2* encodes *ALA2* by performing the same mapping and identification procedures as *ENOR1* (Supplementary Figure [5A](#SM1){ref-type="supplementary-material"}). The *ALA2* gene in *enor2 rdr6* contained a G to A mutation at the 1995th bp, leading to a premature stop codon (Supplementary Figure [5B](#SM1){ref-type="supplementary-material"}), and mutation of *ALA2* by CRISPR/Cas9 in *rdr6* also resulted in severe susceptibility to CMV2aTΔ2b (**Figure [5A](#F5){ref-type="fig"}** and Supplementary Figure [5B](#SM1){ref-type="supplementary-material"}), suggesting that *ALA2* mediates antiviral immunity. Moreover, we generated the *enor1 enor2 rdr6* triple mutant, and found that *enor1 enor2 rdr6* displayed severe developmental defects, including stunted leaves, which is similar with CMV2aTΔ2b-infected *enor1 rdr6* and *enor2 rdr6* (**Figure [5C](#F5){ref-type="fig"}**). This results (**Figure [5](#F5){ref-type="fig"}**) indicate that both *ALA1* and *ALA2* act additively with *RDR6* to mediate antiviral immunity and plant growth.

![***ALA2* acts additively with *RDR6* and redundantly with *ALA1* in antiviral immunity. (A)** Phenotypes of *enor2 rdr6*, and the *ala2-crispr1* mutant generated by CRISPR/Cas9 in *rdr6* (*ala2-crispr1 rdr6*) at 21 days after infection with mock or CMV2aTΔ2b. **(B)** Immunoblotting analysis to detect the accumulations of CMV2aTΔ2b from leaves of *enor1 rdr6* and *enor2 rdr6* at 21 days after infection with mock or CMV2aTΔ2b. The coat protein (CP) of CMV2aTΔ2b was detected by anti-CP (α-CP) antibody. The large subunit of ribulose-1,5-bisphosphate was used as the loading control. **(C)** Phenotypes of 30-day-old seedlings of *rdr6, enor1 rdr6, enor2 rdr6*, and *enor1 enor2 rdr6*.](fpls-08-00422-g005){#F5}

Analysis of Other ALAs in Antiviral Immunity
--------------------------------------------

Phylogenetic analysis of the ALA family proteins showed that ALA1 and ALA2 are the closest members, and other members are less related (Supplementary Figure [6](#SM1){ref-type="supplementary-material"}). We observed that CMV2aTΔ2b infection dramatically induced the expression of *ALA7* and *ALA10* in *ala1-2*, but could not obviously affect the expression of other *ALAs* in wild-type and *ala1-2* (**Figure [6A](#F6){ref-type="fig"}**). We next investigated whether other ALA members play a role in antiviral immunity. The T-DNA insertion mutants of *ALA3* to *ALA12* were inoculated with CMV2aTΔ2b, and the results showed that none of these mutants were susceptible (**Figure [6B](#F6){ref-type="fig"}** and data not shown). It remains to be elucidated whether these ALAs function redundantly to mediate RNAi-based antiviral immunity and plant development.

![**Analysis of ALA members in antiviral silencing. (A)** Quantitative real-time PCR showed the relative expression levels of *ALA* family members in Col-0 and *ala1-2* after inoculation with mock or CMV2aTΔ2b. The data are means (±SE) from three biological repeats. **(B)** Phenotypes of the *ala3, ala7* and *ala10* mutants at 21 days after infection with mock or CMV2aTΔ2b.](fpls-08-00422-g006){#F6}

Discussion
==========

It is well known that the RNAi pathway regulates plant growth, development and immunity. Previous studies have revealed that AGOs, DCLs, RDR1 and RDR6 are essential components of RNAi pathway ([@B9]; [@B30]; [@B37]; [@B6]). In this study, we developed an effective forward genetic screening using 2b-deficient CMV2aTΔ2b, and defined ALA1 and ALA2, membrane-localized proteins (**Figures [1](#F1){ref-type="fig"}, [5](#F5){ref-type="fig"}** and Supplementary Figure [2](#SM1){ref-type="supplementary-material"}) ([@B19], [@B20]), as the new components in the RNAi pathway. ALA1 plays an essential role in gene silencing, and acts additively with RDR1/6 to mediate RNAi-based antiviral immunity and plant development (**Figures [2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}**). ALA2 also participates in antiviral defense and development, and acts redundantly with ALA1 in regulation of plant development in *rdr6* background (**Figure [5C](#F5){ref-type="fig"}**).

A recent study showed that AMP1, a novel key component in RNAi pathway, associates with AGO1 and mediates miRNA-targeted translational inhibition of mRNA on ER membrane ([@B18]). miRNA-guided cleavage can also occur on ER membrane-bound polysomes ([@B17]). These studies take ER into a central stage of small RNAs-mediated silencing ([@B22]; [@B17]). On the other hand, viruses recruit ER membrane and manipulate lipid synthesis, transport and metabolism to form a circumstance essential for viral replication and morphogenesis ([@B12]). Our finding that the ER membrane-localized ALA1 and ALA2 are essential players in silencing pathway and antiviral immunity would help to study and understand both the small RNAs machinery on ER membrane and the roles of lipid transport in silencing and antiviral defense. It would be interesting to investigate whether ALA1 and ALA2 associate with AMP1 and/or AGO1 to mediate gene silencing and antiviral immunity.
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